Leila Alland's Insider Trades & SAST Disclosures
Leila Alland's most recent trade in Abeona Therapeutics Inc was a trade of 36,101 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leila Alland.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 154,366 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 118,265 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 106,468 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Purchase of securities on an exchange or from another person at price $ 4.71 per share. | 16 May 2024 | 11,000 | 82,857 (0%) | 0% | 4.7 | 51,799 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 79,103 (0%) | 0% | 4.6 | 271,143 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 20,414 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 52,200 | 52,200 | - | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 09 Sep 2021 | 100 | 0 | - | 30.3 | 3,025 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 100 | 353,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Sep 2021 | 100 | 100 | - | 3.9 | 390 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 07 Sep 2021 | 3,900 | 0 | - | 30.3 | 117,975 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,900 | 353,950 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Sep 2021 | 3,900 | 3,900 | - | 3.9 | 15,210 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 4,000 | 357,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Aug 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 09 Aug 2021 | 2,198 | 1,802 | - | 35.1 | 77,070 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 09 Aug 2021 | 2,049 | 224 | - | 32.7 | 66,914 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.69 per share. | 09 Aug 2021 | 224 | 0 | - | 36.7 | 8,219 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Jul 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2021 | 4,000 | 361,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 07 Jul 2021 | 2,049 | 0 | - | 32.7 | 66,914 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 07 Jul 2021 | 1,951 | 2,049 | - | 31.9 | 62,300 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 98,168 | 98,168 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 77,181 | 77,181 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 36,279 | 36,279 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 4,000 | 365,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 12 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 12 May 2021 | 2,633 | 1,367 | - | 33.4 | 87,903 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 12 May 2021 | 1,367 | 0 | - | 34.0 | 46,484 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 4,000 | 369,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.80 per share. | 07 May 2021 | 3,842 | 158 | - | 34.8 | 133,702 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.49 per share. | 07 May 2021 | 158 | 0 | - | 35.5 | 5,607 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 4,000 | 373,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Apr 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 07 Apr 2021 | 3,972 | 28 | - | 33.9 | 134,481 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.43 per share. | 07 Apr 2021 | 28 | 0 | - | 34.4 | 964 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges